Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) is well known as a major source for superoxide radical generation in leukocytes. Superoxide radicals play a significant role in brain ischemia-reperfusion (I/R) injury. Recent data have also shown expression of NOX in the brain. However, the manner by which NOX is involved in pathologic processes after cerebral ischemia remains unknown. Therefore, we subjected mice deficient in the NOX subunit, gp91 phox (gp91 phox À/À), those treated with the NOX inhibitor, apocynin, and wild-type (WT) mice to 75 mins of focal ischemia followed by reperfusion. At 24 h of reperfusion, the gp91 phox À/À and apocynin-treated mice showed 50% less brain infarction and 70% less cleaved spectrin compared with WT mice. The levels of 4-hydroxy-2-nonenal, malondialdehyde, and 8-hydroxy-2 0 -deoxyguanosine increased significantly after I/R, indicating oxidative brain injury. NADPH oxidase inhibition reduced biomarker generation. Furthermore, NOX was involved in postischemic inflammation in the brains, as less intercellular adhesion molecule-1 upregulation and less neutrophil infiltration were found in the NOX-inhibited mice after I/R. Moreover, gp91 phox expression increased after ischemia, and was further aggravated by genetic copper/zinc-superoxide dismutase (SOD1) ablation, but ameliorated in SOD1-overexpressing mice. This study suggests that NOX plays a role in oxidative stress and inflammation, thus contributing to ischemic brain injury.
Introduction
Reactive oxygen species play an important role in cerebral ischemia-reperfusion (I/R) damage (Chan, 1996 (Chan, , 2001 . During reperfusion, robust oxidants are generated and are directly involved in the damage to cellular macromolecules, such as lipids, proteins, and nucleic acids, eventually leading to cell death (Chan, 2001) .
Many prooxidant enzymes, including nitric oxide synthase, cyclooxygenase (COX), and xanthine oxidase, participate in oxidative injury in cerebral ischemia (Chan, 2001) . NADPH oxidase (NOX) is originally found in leukocytes and is a major resource of reactive oxygen species generation in them (Lambeth, 2004) . NADPH oxidase is a multisubunit complex composed of membrane-associated gp91 phox and p22 phox subunits and cytosolic subunits, including p47 phox , p67 phox , and p40 phox . As NOX is activated, cytosolic subunits, p47 phox , p67 phox , and p40 phox , translocate into membranes and fuse with the catalytic subunit, gp91 phox . The activated enzyme complex transports electrons to oxygen, thus producing the superoxide anion (O 2 KÀ ), a precursor of reactive oxygen species (Bedard and Krause, 2007) .
Recent studies have also suggested that NOX is expressed in the central nervous system (Bedard and Krause, 2007) . In vitro studies have shown NOX expression in neurons, astrocytes, and in microglia (Bedard and Krause, 2007) . Immunohistochemistry studies have shown that NOX subunits are widely distributed in the cortex, the hippocampus, and in the cerebellum in vivo (Kim et al, 2005; Infanger et al, 2006) . Genetic ablation of the gp91 phox subunit reduced brain infarction by 46% at 22 h of reperfusion after 2 h of focal ischemia (Walder et al, 1997) . However, these studies failed to show how NOX contributes to ischemic brain damage. In this study, we focused on the role of NOX in postischemic oxidant generation and inflammation progression. In addition to prooxidant enzymes, antioxidant enzymes are also robustly expressed in the brain (Chan, 2001) . Copper/zinc-superoxide dismutase (SOD1) is one of the most important antioxidant enzymes and is crucial for reducing oxidant stress after cerebral I/R. Superoxide dismutase knockout (KO) mice are more susceptible to focal ischemia challenge (Kondo et al, 1997) . However, crosstalk between the oxidant-generation enzyme, NOX, and the antioxidant enzyme, SOD1, after cerebral ischemia remains unknown.
In this study, we used both genetic gp91 phox ablation and the NOX inhibitor, apocynin, to investigate the role of NOX in cerebral I/R damage. We found that the inhibition of NOX alleviated oxidative stress and reduced the inflammation process after cerebral focal ischemia, and subsequently protected the brain against I/R damage. In addition, we found that cerebral I/R causes upregulation of the NOX subunit, gp91 phox , and that postischemic gp91 phox overexpression was regulated by the level of endogenous SOD1.
Materials and methods
Animal Preparation gp91 KO mice that were developed and maintained in the C57BL/6J strain were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and were characterized earlier (Pollock et al, 1995) . Superoxide dismutase-deficient mice, including SOD1 heterozygous (SOD1À/ + ) and SOD1 KO mice, designated CD1-SOD1 < tm1 Cje > , were produced by Epstein et al (Kondo et al, 1997) . Superoxide dismutase transgenic (TG) mice of the SOD1 TGHS/SF-218 strain were derived from the founder stock described earlier (Epstein et al, 1987) . No phenotypic differences were observed among the gp91 KO and wild-type (WT) mice or the SOD1 TG, SOD1 KO, and WT mice. Mouse genotypes were determined by a PCR of DNA from tail biopsies. Male adult mice (weighing 25 to 30 g) were anesthetized with 5% isoflurane for induction and 1.0% isoflurane vaporized in N 2 O and O 2 (3:2) for maintenance. Rectal temperatures were monitored and maintained at 37.01C±0.51C with a homeothermic blanket control unit (Harvard Apparatus, Holliston, MA, USA). Artery blood samples were collected and analyzed for blood gas and electrolytes before and during the middle cerebral artery occlusion (MCAO) using an I-STAT analyzer (I-STAT, East Windsor, NJ, USA).
Focal Cerebral Ischemia Models in Mice
Focal cerebral ischemia was induced in the mice by occlusion of the left middle cerebral artery (MCA) using a 6-0 coated suture as described before (Chen et al, 2005) . Briefly, the left common carotid artery was exposed and the external carotid artery was dissected distally. The internal carotid artery (ICA) was isolated and a coated suture (6-0 monofilament nylon) was introduced into the external carotid artery lumen and then gently advanced into the ICA lumen to block MCA blood flow. A successful occlusion was indicated by a decrease in the regional cerebral blood flow (CBF) to < 20% of the baseline. After 75 mins of MCAO, CBF was restored by suture withdrawal. The incision was closed and the mice recovered under a heating lamp. The animals were divided into three groups, namely WT, apocynin-treated, and gp91 KO. Before apocynin treatment, preliminary studies were carried out using various doses and an optimal dose was chosen. Thus, for apocynin treatment, 4 mg/kg body weight (Sigma-Aldrich, St Louis, MO, USA) was administered by intraperitoneal injection 5 mins before suture withdrawal. In our pilot experiments, there was no significant difference in brain infarction between WT and vehicle-treated mice (0.25 ml normal saline, intraperitoneal). In addition, for a better comparison between the WT and gp91 KO mice, we used WT mice without vehicle treatment in this study. All animal procedures used in this study were conducted in strict compliance with the NIH Guide for the Care and Use of Laboratory Animals, and was approved by Stanford University's Administrative Panel on Laboratory Animal Care.
Regional Cerebral Blood Flow Measurement
Changes in regional CBF at the surface of the left cortex were recorded using a blood flow monitor (Laserflo BMP 2 ; Vasamedics, Eden Prairie, MN, USA) with a fiber optic probe. The tip of the probe was over the core area supplied by the MCA (2 mm posterior and 6 mm lateral from the bregma). Changes in CBF after MCAO were expressed as a percentage of the baseline value.
Examination of Neurologic Symptoms
The mice were examined for neurologic deficits at 3 and 24 h of reperfusion after MCAO using a modified five-point scale as reported: grade 0, no observable neurologic deficit (normal); grade 1, flexion of the contralateral torso and the forelimb upon lifting of the animal by its tail (mild); grade 2, circling to the contralateral side but normal posture at rest (moderate); grade 3, leaning to the contralateral side at rest (severe); grade 4, no spontaneous motor activity (very severe) (Bederson et al, 1986; Yang et al, 1994) .
Measurement of Infarct Volume
After 24 and 72 h of reperfusion, the mice were anesthetized and then decapitated. Coronal sections were cut into 2-mm slices using a mouse-brain matrix (Zivic Instruments, Pittsburgh, PA, USA), and were immediately immersed in 2% TTC (2,3,5-triphenyltetrazolium chloride) (Sigma-Aldrich) for 20 mins. The infarction area in each section was calculated using the NIH image analysis software (Bethesda, MD, USA). The infarct areas of each slice were separately summed and multiplied by the interval thickness to obtain infarct volumes as described before (Chen et al, 2005) .
Western Blotting
Whole-cell fractions were obtained from the entire MCA territory (ischemic and nonischemic sides). Tissues were lysed by lysis buffer (Cell Signaling Technology, Danvers, MA, USA), followed by 30 secs of sonication at 41C using an ultrasonic processor (VC 130 PB; Sonic & Materials Inc., Newtown, CT, USA). Protein concentration was determined using a bicinchoninic acid method. Equal amounts of samples were loaded per lane and were then electrophoretically separated on sodium dodecyl sulfate (SDS) gels. The resolved proteins were electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane. The primary antibodies were an anti-a-spectrin antibody (1:5,000; Millipore, Billerica, MA, USA ), an anti-COX-2 antibody (1:1,000; Cayman, Ann Arbor, MI, USA), an anti-gp91 phox antibody (1:1,000; BD Bioscience, Franklin Lakes, NJ, USA), an antimouse intercellular adhesion molecule-1 (ICAM-1) (1:1,000; Biolegend, San Diego, CA, USA), and an antib-actin antibody (1:20,000; Sigma-Aldrich). Western blotting was performed with horseradish peroxidase-conjugated secondary IgG (Cell Signaling Technology) with the use of enhanced chemiluminescence detection reagents. Quantitative expression of the proteins was analyzed by scanning the films of the blots and calculating the intensity as measured by Quantity One software (Bio-Rad, Hercules, CA, USA).
Immunohistological Staining
For immunohistochemistry after I/R, the mice were perfused with heparin in saline (2 IU/L), followed by 4% paraformaldehyde. The brains were postfixed in 4% paraformaldehyde overnight, and subsequently cryoprotected with 20% and 30% sucrose. The brains were cut into coronal sections (30 mm) on a freezing microtome (SM 2000R; Leica, Nussloch, Germany). Two coronal sections (0.98 mm anterior and 1.06 mm posterior to the bregma) were selected and processed for immunohistological staining. The sections were probed with an antibody against 8-hydroxy-2 0 -deoxyguanosine (8-OHdG) (1:400; GeneTex, San Antonio, TX, USA) and an anti-4-hydroxy-2-nonenal (HNE) antibody (1:400; Alpha Diagnostic International, San Antonio, TX, USA). The sections were incubated with biotinylated antigoat IgG (1:400; Vector Laboratories, Burlingame, CA, USA) and avidin-peroxidase (Vector Laboratories). Color reaction was developed using a diaminobenzidine kit (Vector Laboratories). For a negative control, a consecutive section was treated with similar procedures, except that the primary antibody was omitted. Images were observed and captured using a Zeiss optical microscope (Axioplan2, Thornwood, NY, USA). 8-OHdGpositive cells were counted and averaged in four subsequent areas at each section as described before (Franklin and Paxinos, 1997; McColl et al, 2007) .
Malondialdehyde Detection
Intracellular malondialdehyde (MDA) is a biomarker for lipid peroxidation. After I/R, MDA levels in ischemic and contralateral hemispheres were measured using a Biox-ytech LPO-586 assay kit (OxisResearch, Foster City, CA, USA) according to the manufacturer's instructions. Intracellular malondialdehyde concentration was calculated by measuring the absorbance at 586 nm on a spectrophotometer (Molecular Devices, Sunnyvale, CA, USA), using N-methy-2-phenylindole as a substrate.
Myeloperoxidase Measurement
Myeloperoxidase (MPO) is an active enzyme expressed in neutrophils and involved in phagocytic lysis of engulfed foreign particles. After I/R, MPO levels in ischemic and nonischemic hemispheres were measured with a Mouse MPO ELISA kit (Hycult Biotechnology, Uden, The Netherlands) according to the manufacturer's instructions. Samples were measured on a spectrophotometer (Molecular Devices) at 586 nmol/L, and the MPO concentration was calculated with a standard curve according to the manufacturer's instructions.
Quantification and Statistical Analysis
The data are expressed as mean ± s.e.m. Comparison between groups was achieved with analysis of variance (ANOVA) using the Fisher protected least-significant difference (PLSD) test. Significance was accepted at P < 0.05 (StatView; Adept Scientific Inc., Acton, MA, USA).
Results

NOX Inhibition Reduced Brain Infarction After Ischemia-Reperfusion
Physiologic parameters showed no significant differences in arterial blood gas and electrolytes between the groups. The preischemic physiologic values were as follows (WT and gp91 KO mice, respectively): 146±24 and 132±10 mm Hg PaO 2 ; 39 ± 2.4 and 43 ± 5.8 mm Hg PaCO 2 ; pH 7.38 ± 0.03 and 7.39 ± 0.05; Na 146 ± 0.6 and 145 ± 0.3 mmol/L; and K 4.3±0.4 and 4.6±0.2 mmol/L (n = 3 to 5). During ischemia, the physiologic values were as follows: 130 ± 10 and 112 ± 6 mm Hg PaO 2 ; 45 ± 4 and 39±4 mm Hg PaCO 2 ; pH 7.34±0.02 and 7.4±0.09; Na 147±1.1 and 146±1.7 mmol/L; and K 4.2±0.3 and 5.0 ± 0.7 mmol/L (n = 3 to 5).
To investigate the role of NOX in ischemic brain damage, infarction volume was assessed in the WT, apocynin-treated, and gp91 KO brains after I/R. The average infarction volume in the WT mice was 53.9±8.6 mm 3 after 75 mins of focal ischemia and 24 h of reperfusion ( Figure 1A and 1C ). The predominant lesion was found in a region 4 to 6 mm posterior to the frontal pole, in which the blood supply is primarily from the MCA. In the apocynintreated and gp91 KO mice, infarction volume was significantly less than in the WT mice (24.9±6.9 and 26.0±4.8 mm 3 , apocynin-treated and gp91 KO, respectively, P < 0.05, Figure 1A and 1C).
We further measured the brain infarct at 72 h of reperfusion after ischemia. Similarly, a larger infarction tissue was observed in the WT mice than in the apocynin-treated and gp91 KO mice (106.2±12.5, 57.7±15.8, and 52.0±11.8 mm 3 , respectively, P < 0.05, Figure 1B and 1D). The difference in brain infarction among the WT, apocynin-treated, or gp91 KO mice is not likely because of the cerebral vascular change after NOX inhibition, because the brain blood flow decreased to a similar level among the three groups during ischemia (12% to 14.6%, P > 0.05, Figure 1E and 1F).
NOX Inhibition Ameliorated Cleaved Spectrin and Improved Neurologic Function After Ischemia-Reperfusion
To study the cellular mechanism of brain damage, we examined cleaved spectrin after I/R. Spectrin is a cytoskeletal protein that lines the intracellular side of the plasma membrane, forming a scaffolding and maintaining plasma membrane integrity. Cleaved spectrin can cause cytoskeleton destruction and bleb formation in the cell membrane, ultimately degrading cells and leading to cell death (Bü ki et al, 2000) .
We used a spectrin antibody that recognizes both caspase (150 and 120 kDa) and calpain (150 kDa) cleaved products to assess brain injury after I/R. At 3 h of reperfusion, a large amount of cleaved spectrin products (150 kDa) was found in the WT mice. The ratio of spectrin density between the ipsilateral and contralateral sides in the WT mice was B2.4, which is significantly higher than in the apocynin-treated and gp91 KO mice (1.24 to 1.45, P < 0.05, Figure 2A and 2C). Only very limited cleaved spectrin products were shown at 120 kDa by the same blot (1.08 to 1.14, Figure 2A and 2C). At 24 h of reperfusion, pronounced cleaved spectrin products (both 150 and 120 kDa) were found in the WT brain tissue (B2.30, B1.92; 150 and 120 kDa, respectively, Figure 2B and 2D). If apocynin was present, cleaved spectrin products were reduced (B1.40, B1.08; 150 and 120 kDa, respectively, P < 0.05, Figure 2B and 2D). The gp91 KO mice also showed less cleaved spectrin compared with the WT mice (B1.36, B1.1; 150 and 120 kDa, respectively, P < 0.05, Figure 2B and 2D). These data suggest that NOX activity contributed to cleaved spectrin after cerebral I/R.
We then investigated whether NOX inhibition improved neurologic function after I/R. At 3 h of reperfusion, the animals showed prominent neurologic deficits, with no significant differences in neurologic-deficit scores among the WT, apocynintreated, and gp91 KO groups (P > 0.05, Figure 2C ). However, after 24 h of reperfusion, the average neurologic-deficit score for the WT mice was B2.8, which was significantly higher than for the apocynin-treated or gp91 KO mice (1.9 to 2.0, P < 0.05, Figure 2E ). These data indicate that mice subjected to NOX inhibition not only had less ischemic infarct but also maintained better neurologic function. , and gp91 KO mice (*P < 0.05 versus WT mice, n = 5 to 11). WT mice showed larger brain infarct volume than apocynin-treated and gp91 knockout (KO) mice. (D) Infarct volume at 72 h of reperfusion after MCAO in WT, apocynin-treated, and gp91 KO mice (*P < 0.05 versus WT mice, n = 5 to 6). WT mice showed larger brain infarct than apocynin-treated and gp91 KO mice. (E) Representative changes in cerebral blood flow (CBF) level during MCAO among WT, apocynin-treated, and gp91 KO mice. (F) Summarized data of CBF decrease in WT, apocynin-treated, and gp91 KO mice during ischemia (P > 0.05, n = 4 to 11).
Figure 2
Cleaved spectrin and neurologic deficit scores in wild-type (WT), apocynin-treated (Apo), and gp91 knockout (KO) mice. (A) Western blot analysis of cleaved spectrin at 3 h of reperfusion. Significant cleaved spectrin products (150 kDa) were detected in the WT mice, but not in the apocynin-treated and gp91 KO mice. Contra, contralateral; Ipsi, ipsilateral. (B) Western blot analysis of cleaved spectrin at 24 h of reperfusion. NOX inhibition reduced cleaved spectrin products (both 150 and 120 kDa). (C) Summarized data from panel A. *P < 0.05 versus WT spectrin (150 kDa), n = 6. Summarized data are presented as a ratio of (cleaved spectrin/uncleaved spectrin)/b-actin, which are normalized to the contralateral side. (D) Summarized data from panel B. *P < 0.05 versus WT spectrin (120 kDa); #P < 0.05 versus WT spectrin (150 kDa), n = 4 to 6. Summarized data are presented as described in panel C. (E) Neurologic deficit score measurement at 3 and 24 h of reperfusion. NOX inhibition had no significant effect on postischemic neurologic deficit scores at 3 h of reperfusion. However, at 24 h of reperfusion, the neurologic deficit scores in the WT mice were significantly higher than in the apocynin-treated and gp91 KO mice *P < 0.05 versus WT mice at 24 h of reperfusion, n = 7 to 16.
NOX Inhibition Alleviated Oxidative Stress In Vivo After Ischemia-Reperfusion
We examined the role of NOX in postischemic oxidative injury in mouse brains by measuring the lipid peroxidation products, HNE and MDA. Low HNE immunoactivity was detected in the contralateral hemisphere (data not shown). However, a number of HNE-positive cells were observed on the ipsilateral side of the WT brains at 24 h of reperfusion after focal ischemia ( Figure 3A) . After NOX inhibition, there were fewer HNE-positive cells in the ischemic brains compared with the WT mice ( Figure 3A) . We also measured the concentration of MDA in the brain tissue. In the contralateral hemisphere, there was no significant difference in MDA concentration among the WT, apocynin-treated, and gp91 KO mice, indicating similar baseline conditions (111 to 130 pmol/mg protein, Figure 3B ). After I/R, MDA generation was increased B1.5-fold in the ipsilateral brains of the WT animals compared with the contralateral side, and was significantly higher than in the apocynin-treated and gp91 KO mice (0.97-to 1.07-fold, P < 0.05, Figure 3B ).
DNA oxidative damage was assessed by immunohistological staining using an 8-OHdG antibody. 8-OHdG, an oxidized nucleoside of DNA and an indicator of a DNA oxidative lesion, was not detected in the contralateral hemisphere (data not shown). We also did not find 8-OHdG-positive cells at 3 h of reperfusion ( Figure 3D) . In contrast, a significant amount of 8-OHdG-positive cells was observed on the ipsilateral side of the WT brains at 24 h of reperfusion after focal ischemia (69.2±8.1/0.15 mm 2 , Figure 3D and 3E). 8-OHdG immunoactivity was not as prominent in the apocynin-treated and gp91 KO mice as in the WT mice (33.4±7.8/0.15, 32.7±12.3/ 0.15 mm 2 , P < 0.05, Figure 3D and 3E) .
NADPH Oxidase and the Inflammation Process After Ischemia-Reperfusion
Significant cerebral inflammation occurs after cerebral ischemia and it may exacerbate brain damage (Danton and Dietrich, 2003) . To further characterize the role of NOX in the postischemic pathologic process, especially inflammation progress, we examined the expression of ICAM-1, which is an intercellular interaction molecule and mediates neutrophils recruited into the brain parenchyma. Western blotting showed minimal ICAM-1 expression in the contralateral hemisphere ( Figure 4A ). After ischemia and 24 h of reperfusion, ICAM-1 expression increased B1.8-fold in the WT ipsilateral hemisphere compared with the contralateral side, and upregulation of ICAM-1 in the WT mice was significantly higher than in the apocynin-treated and gp91 KO mice (B1.1-fold, P < 0.05, Figure 4B ). We then detected neutrophil infiltration by measuring the concentration of the neutrophil-specific enzyme MPO in the brain. In the contralateral hemisphere, MPO concentration was low and there was no significant difference among the WT, apocynintreated, and gp91 KO mice (2.8 to 3.2 ng/mg protein, Figure 4B ). At 24 h of reperfusion, MPO concentration increased to B8.2 ng/mg protein in the WT ipsilateral hemisphere, which suggests neutrophil infiltration. In the apocynin-treated and gp91 KO groups, MPO increase was significantly less than in the WT mice (3.5 to 3.7 ng/mg protein, P < 0.05, Figure 4C ). Finally, we detected COX-2 expression after I/R. All three groups showed similar levels of In the ipsilateral hemisphere, MPO concentration was significantly higher in the WT group than in the apocynintreated or gp91 KO mice (*P < 0.05 versus WT ipsilateral side, n = 4 to 6). (D) Western blot analysis of cyclooxygenase-2 (COX-2) expression after I/R. COX-2 expression increased in the mouse brains after I/R. (E) Summarized data from panel D are presented as a ratio of COX-2/b-actin, which are normalized to the contralateral side. There were no significant differences in COX-2 expression among the WT, apocynin-treated, and gp91 KO mice after I/R (P > 0.05, n = 3 to 5). COX-2 upregulation (1.6-to 1.8-fold increase compared with the contralateral side) in the ipsilateral hemisphere after focal ischemia (P > 0.05, Figure 4D and 4E).
Crosstalk Between NADPH Oxidase and Superoxide Dismutase
To study the interaction between the prooxidant enzyme, NOX, and the antioxidant enzyme, SOD1, we examined gp91 phox expression in the WT, SOD1 KO, and SOD1 TG mice after focal ischemia. After ischemia, a significant increase in gp91 phox protein was found, especially at 1 h of reperfusion ( Figure 5A  and 5B ). However, the amount of gp91 phox in the SOD1 TG mice was much less than that in the WT mice after focal ischemia (*P < 0.05, Figure 5A and 5B). Furthermore, we compared gp91 phox expression among the WT, SOD1À/ + , and SOD1 KO mice after mild ischemia (30 mins), because of the high sensitivity of SOD1 KO to prolonged ischemia. We did not find significant differences between the WT and SOD1À/ + mice (P > 0.05, Figure 5C and 5D ). However, in the SOD1 KO mice, there was significantly more gp91 phox upregulation than in the WT mice after focal ischemia at 1 and 4 h of reperfusion (*P < 0.05, Figure 5C and 5D ).
Discussion
Inhibition of NADPH Oxidase is Neuroprotective in Ischemic Damage
This study shows that the genetic ablation of gp91 phox or the pharmacological inhibition of NOX reduced brain infarction by B53% after 75 mins of ischemia and 24 h of reperfusion. This was further proved by less cleaved spectrin in mouse brains subjected to NOX inhibition. To further examine whether NOX inhibition indeed protects the brain or just delays the progress of brain damage after ischemia, we measured infarction volume in the mice at 72 h of reperfusion after focal ischemia. The brains showed more infarction volume than at 24 h, which suggests a delayed cell death process. The gp91 KO or apocynin-treated mice still showed 46% to 50% less brain infarction than the WT mice at 72 h of reperfusion. Taken together, these data suggest that the inhibition of NOX is neuroprotective after cerebral ischemia. In addition, the spectrin antibody, which recognizes cleaved spectrin products by both caspase (150 and 120 kDa) and calpain (150 kDa), was used to assess brain injury after I/R. Cleaved spectrin has been reported in a variety of cerebral pathologic conditions, including traumatic brain injury and brain focal ischemia (Copin et al, 2005; Deng-Bryant et al, 2008) . Oxidative stress plays an important role in the process of cleaving spectrin, because oxidative stress causes Ca 2 + homeostasis disturbance, which induces calpain-mediated cleavage of spectrin (Deng-Bryant et al, 2008) . Indeed tempol, a catalytic scavenger of free radicals, not only attenuated protein nitration but also inhibited cleavage of spectrin after traumatic brain injury (Deng-Bryant et al, 2008) . In addition, EUK-134, a synthetic SOD1 and catalase mimetic, prevented oxidative stress and cleaved spectrin after kainate intracerebral injection in vivo (Rong et al, 1999) . In our study, Western blotting showed both 150-and 120-kDa products at 24 h of reperfusion, although only 150-kDa cleaved products were detected at 3 h of reperfusion. Therefore, we postulate that at early reperfusion (3 h), the calpain pathway is already activated and can subsequently cause cell necrosis (Lipton, 1999) . In contrast, both calpain-mediated necrosis and caspase-mediated apoptosis play a role in ischemic brain damage at late Figure 5 Crosstalk between NOX and superoxide dismutase (SOD1) after focal ischemia. (A) Decreased levels of gp91 phox expression in the SOD1 transgenic (TG) mouse brains compared with those in the wild-type (WT) brains after 30 mins of MCAO. s, sham (B) Summarized data from panel A (*P < 0.05 versus WT mice at the same time points, n = 3). (C) In the SOD1 knockout (KO) mice, gp91 phox levels were significantly increased at 1 and 4 h compared with that in the WT or heterozygous (HE) mice after focal ischemia. (D) Summarized data from (C) (*P < 0.05 versus SOD1 WT mice, n = 4). reperfusion (24 h) (Lipton, 1999) . Consistent with our findings, earlier studies reported that active caspase-3 showed a significant increase at 24 h of reperfusion, but not at 6 h of reperfusion after MCAO (Wang et al, 2008) . We also detected a 2-to 2.3-fold larger infarction volume at 3 days than at 24 h of reperfusion, which indicates a continuous evolution of cell death, leading to a delayed larger infarction. More studies are required to determine which cell death signal pathway contributes to delayed brain cell death.
In addition to neutrophils, recent data have identified that NOX also expresses in neurons, microglia, and astrocytes constitutively, in which it may function as in physiologic redox signals (Bedard and Krause, 2007) . We hypothesize that NOX activation in the brain tissue can contribute to oxidant generation and subsequent brain damage in vivo after cerebral focal ischemia. In vitro studies showed a large amount of O 2 KÀ generation and significant cell death in cultured neurons with GD/GR (glucose deprivation and glucose reperfusion) treatment (Suh et al, 2007) . Inhibition of NOX by p47 phox subunit ablation can abolish GD/GR-induced O 2 KÀ production and prevent neuronal death (Suh et al, 2007) . Apocynin can also reduce O 2 KÀ generation in cultured neurons subjected to oxygen-GD treatment (Suh et al, 2008) . We observed a significant amount of lipid or DNA peroxidation products, including MDA, HNE, and 8-OHdG, at 24 h of reperfusion in the WT mice. In addition, we observed fewer HNE and MDA products and less DNA oxidation in the gp91 KO and apocynin-treated mice. Moreover, we found that NOX inhibition by apocynin reduced O 2 KÀ generation in mouse brains at 3 h of reperfusion using a hydroethidine injection in vivo (data not shown). Taken together, these data support the view that inhibition of NOX reduces free radical generation and alleviates brain oxidative damage, subsequently reducing brain infarction in vivo.
Alleviation of Postischemic Inflammation Progress After NADPH Oxidase Inhibition
There is substantial evidence that inflammation occurs after focal cerebral ischemia and that it is implicated as a secondary injury mechanism (Danton and Dietrich, 2003) . Cerebral postischemic inflammation is characterized by the upregulation of inflammation mediators and infiltration of inflammatory cells, such as neutrophils and microglia in the ischemic brain (Barone and Feuerstein, 1999) . Recruitment of neutrophils into the brain parenchyma is initiated by both chemoattractants within the brain and by binding to adhesion molecules (such as ICAM-1) on the surface of endothelial cells. Earlier reports showed that neutrophils infiltrated into the postischemic brain parenchyma as early as 6 h and that neutrophil infiltration can cause detrimental effects through reocclusion of the microvasculature, producing reactive oxygen species and releasing more proinflammatory mediators, such as tumor necrosis factor-a, and interleukin-1b, thus potentially amplifying the cellular inflammatory response (Danton and Dietrich, 2003; Wang et al, 2007; Weston et al, 2007) . Mice that have neutrophil immunodepletion showed a 3.0-fold decrease in infarct volume, reduced neurologic deficit, and less mortality compared with controls after 2 h of focal ischemia and 24 h of reperfusion (Connolly et al, 1996) . In our study, significantly less MPO expression was found in the apocynin-treated and gp91 KO mice, which indicates less neutrophil accumulation after NOX inhibition. Intercellular adhesion molecule-1 is constitutively expressed in the endothelium of the brain microvascular structure at low concentrations. After cerebral ischemia, it is upregulated by cytokines and binds b2 integrins on neutrophils, thus mediating neutrophil adhesion and transmigration into the brain parenchyma (Frijns and Kappelle, 2002; Panés et al, 1999) . Knockout of ICAM-1 caused a degree of brain protection similar to neutrophil depletion in a focal ischemia model (Connolly et al, 1996) . We found that ICAM-1 upregulation was less significant in the gp91 KO and apocynin-treated mice than in the WT mice at 24 h of reperfusion. This further strengthened our hypothesis that NOX inhibition reduces neutrophil infiltration after cerebral ischemia. Taken together, our data suggest that in addition to reducing oxidant stress, NOX inhibition can also protect against cerebral damage by alleviating inflammation processes, such as neutrophil infiltration. In our study, NOX inhibition failed to inhibit expression of the inflammationinduced protein, COX-2. This suggests that ICAM-1 upregulation and neutrophil infiltration is mediated by NOX instead of COX-2-mediated pathways. We speculate that NOX activation mediates the inflammation process through changes in the redox state in the brain after ischemia. Oxidative stress plays an important role in the regulation of the postischemic neuro-inflammation process. Gene expression studies have shown that after ischemia, an increase in oxygen radicals triggers expression of a number of proinflammatory genes that are regulated by the redox-sensitive transcription factor, nuclear factor-k-B (Chan, 2001; Song et al, 2007) . Nevertheless, the molecules and pathways that are activated by NOX and that mediate changes in postischemic inflammation need further elucidation.
Apocynin is a commonly used NOX inhibitor with relatively low affinity (IC50 B10 mmol/L) in neutrophils (Simons et al, 1990) . Apocynin inhibits the release of O 2 KÀ through NOX by blocking migration of p47 phox to the membrane, thus interfering with assembly of the functional NOX complex (Touyz, 2008) . It was reported that apocynin needs MPO activation to form a dimer before inhibiting p47 phox translocation (Heumü ller et al, 2008) . In cells that are not rich in MPO, apocynin can reduce oxidant stress through a nonspecific oxidative scavenger effect instead of NOX inhibition (Heumü ller et al, 2008) . However, besides MPO, other peroxidases, such as horseradish peroxidase, can also induce an apocynin dimer formation with a consequent NOX inhibitory effect (Touyz, 2008; Vejrazka et al, 2005) . In addition, in vivo studies showed that MPO secreted by neutrophils can be taken up by endothelial cells, in which apocynin can then be metabolized to active dimers, thus inhibiting vascular cell NOX (Touyz, 2008) . Our study showed an B3-fold increase in MPO concentration after ischemia in the WT mice. Thus, we speculate that apocynin acted as an NOX inhibitor either through MPO generated by neutrophils or through peroxidase, although the direct scavenger effect of apocynin needs to be further examined. In addition, the gp91 KO mice also showed a protective effect similar to that observed with apocynin treatment, which strengthens our conclusion that inhibition of NOX is neuroprotective after cerebral ischemia. It was reported that apocynin improved the outcome in MCAO at a low dosage (2.5 mg/kg intravenously), but increased intracerebral hemorrhage at 5 mg/kg (Tang et al, 2008) . This could be because of the longer period of ischemia (120 mins) and larger infarction (B140 mm 3 ) in that study. Thus, the mice were less tolerant to apocynin. Furthermore, apocynin was administered intravenously and the absorption was faster and more complete (Tang et al, 2008) . We administered apocynin 4 mg/kg intraperitoneally, and no significant side effect was observed.
Crosstalk Between Superoxide Dismutase and NOX After Cerebral Ischemia
Our results show that gp91 phox expression is increased after focal ischemia. In agreement with our view, upregulation of gp91 mRNA and protein was also reported in other studies, such as that using a rat focal ischemia model (Kusaka et al, 2004) . We further investigated crosstalk between the prooxidant enzyme, NOX, and the antioxidant enzyme, SOD1, which is an important endogenous cytosolic antioxidant enzyme (Chan, 2001) . The SOD1 TG mice, which have a 2.3-fold overexpression of SOD1 in the brain tissue, showed 40% less brain infarct and edema, as well as less O 2 KÀ generation in the brain than the WT mice after I/R (Epstein et al, 1987; Kinouchi et al, 1991; Noshita et al, 2002) . In contrast, generation of more O 2 KÀ and exacerbation of neuronal death were shown in the SOD1À/ + mice with a 50% decrease in SOD1 activity after global ischemia (Kawase et al, 1999) . Our results show that the SOD1 KO mice have a 1.8-to 2.8-fold greater increase in gp91 phox than the WT mice after focal ischemia. This suggests that NOX expression is regulated by the redox state of the brain tissue and that oxidative stress contributes to NOX upregulation in the brain tissue. To further strengthen our hypothesis, we tested gp91 phox expression in the SOD1 TG mice after focal ischemia. Indeed, we found that gp91 phox upregulation after cerebral ischemia is less pronoun-ced in SOD1 TG mice than in WT mice. Therefore, NOX activity can itself be potentially subjected to feed-forward regulation after SOD1 mutation. In addition to antioxidant-ability deficit, the SOD1 KO mice showed more significant NOX upregulation, which generates more endogenous O 2 KÀ , thereby amplifying the progress of brain injury after focal ischemia. In contrast, less vulnerability to ischemic insult in the SOD1 TG mice is attributed to both higher SOD1 levels and less O 2 KÀ generated by NOX. Moreover, we found that apocynin administration reduced infarction by > 50% in manganese SOD1 KO mice after 30 mins of ischemia and 72 h of reperfusion (unpublished data). This further suggests that the elaborate crosstalk between NOX and SOD and that the inhibition of NOX can be a new therapeutic target for antioxidant-enzyme deficit.
In conclusion, the results from both pharmacological inhibition and genetic ablation studies show that NOX contributes to ischemic cerebral damage, through increasing oxidant generation and aggravation of the inflammation process. In addition, NOX expression is regulated by the redox state after cerebral ischemia. Our findings further stress the important role of NOX in brain ischemic damage.
